Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Vehicle-controlled, Double-Masked, Randomized Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of AGN-242428 and AGN-231868 in Participants With Dry Eye Disease

NCT04030962 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT04030962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04030962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Vehicle-controlled, Double-Masked, Randomized Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of AGN-242428 and AGN-231868 in Participants With Dry Eye Disease
Lead sponsor
AbbVie
Phase
Phase 1/2
Overall status
Completed
Start date
March 4, 2020
Completion date
March 18, 2022
Enrollment
292 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease, dry eye syndrome